(Q37943790)

25 August 2017

Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? (English)

1 reference

head and neck squamous cell carcinoma

25 August 2017

0 references

Robert Snoeck

3

0 references

author name string

Nadine C Olthof

1

1 reference

25 August 2017

Jos M J A A Straetmans

2

1 reference

25 August 2017

Frans C S Ramaekers

4

1 reference

25 August 2017

Bernd Kremer

5

1 reference

25 August 2017

Ernst-Jan M Speel

6

1 reference

25 August 2017

7 October 2011

1 reference

Reviews in Medical Virology

25 August 2017

1 reference

25 August 2017

22

1 reference

25 August 2017

2

1 reference

25 August 2017

88-105

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

25 August 2017

1 reference

21 January 2018

Cancer statistics, 2008

1 reference

Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

21 January 2018

1 reference

The role of Epstein-Barr virus in cancer

21 January 2018

1 reference

Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database

21 January 2018

1 reference

A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8

21 January 2018

1 reference

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis

21 January 2018

1 reference

Clinical implications of human papillomavirus in head and neck cancers

21 January 2018

1 reference

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?

21 January 2018

1 reference

Classification of papillomaviruses

21 January 2018

1 reference

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

21 January 2018

1 reference

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification

21 January 2018

1 reference

Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses

21 January 2018

1 reference

Current understanding of the mechanism of HPV infection

21 January 2018

1 reference

alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP.

21 January 2018

1 reference

Mechanisms of cell entry by human papillomaviruses: an overview

21 January 2018

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.

21 January 2018

1 reference

HPV E6 protein interacts physically and functionally with the cellular telomerase complex

21 January 2018

1 reference

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

21 January 2018

1 reference

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

21 January 2018

1 reference

A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.

21 January 2018

1 reference

Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers

21 January 2018

1 reference

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study

21 January 2018

1 reference

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities

21 January 2018

1 reference

Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.

21 January 2018

1 reference

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

21 January 2018

1 reference

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.

21 January 2018

1 reference

Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma.

21 January 2018

1 reference

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.

21 January 2018

1 reference

Human papillomavirus and oropharyngeal cancer.

21 January 2018

1 reference

Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas

21 January 2018

1 reference

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands

21 January 2018

1 reference

Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis

21 January 2018

1 reference

Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas

21 January 2018

1 reference

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas

21 January 2018

1 reference

Oral sexual behaviors associated with prevalent oral human papillomavirus infection

21 January 2018

1 reference

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

Human papillomavirus and head and neck cancer: epidemiology and molecular biology

21 January 2018

1 reference

Human papillomavirus type 16 in head and neck carcinogenesis.

21 January 2018

1 reference

p16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV.

21 January 2018

1 reference

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

21 January 2018

1 reference

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.

21 January 2018

1 reference

The role of human papillomavirus in head and neck cancer

21 January 2018

1 reference

HPV-associated head and neck cancer: a virus-related cancer epidemic

21 January 2018

1 reference

Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.

21 January 2018

1 reference

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

21 January 2018

1 reference

Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus

21 January 2018

1 reference

Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.

21 January 2018

1 reference

P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis.

21 January 2018

1 reference

Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer

21 January 2018

1 reference

Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications

21 January 2018

1 reference

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

21 January 2018

1 reference

HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation.

21 January 2018

1 reference

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

21 January 2018

1 reference

The molecular biology of head and neck cancer

21 January 2018

1 reference

Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review

21 January 2018

1 reference

Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells

21 January 2018

1 reference

Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas

21 January 2018

1 reference

Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.

21 January 2018

1 reference

Gene expression profiles in HPV-infected head and neck cancer

21 January 2018

1 reference

Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus

21 January 2018

1 reference

Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue

21 January 2018

1 reference

Transoral resection of tonsillar squamous cell carcinoma

21 January 2018

1 reference

Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer.

21 January 2018

1 reference

Current trends in initial management of oropharyngeal cancer: the declining use of open surgery.

21 January 2018

1 reference

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

21 January 2018

1 reference

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

21 January 2018

1 reference

Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status

21 January 2018

1 reference

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence

21 January 2018

1 reference

Human papillomavirus and survival of patients with oropharyngeal cancer.

21 January 2018

1 reference

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

21 January 2018

1 reference

Human papillomavirus-related head and neck tumors: clinical and research implication

21 January 2018

1 reference

A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention

21 January 2018

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

21 January 2018

1 reference

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

21 January 2018

1 reference

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.

21 January 2018

1 reference

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

21 January 2018

1 reference

Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III

21 January 2018

1 reference

Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.

21 January 2018

1 reference

Development of therapeutic HPV vaccines

21 January 2018

1 reference

Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer

21 January 2018

1 reference

Human papillomaviruses and the interferon response

21 January 2018

1 reference

Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes

21 January 2018

1 reference

Interferon for the treatment of genital warts: a systematic review

21 January 2018

1 reference

Randomized placebo-controlled evaluation of intramuscular interferon beta treatment of recurrent human papillomavirus

21 January 2018

1 reference

Recombinant human interferon-beta for condylomata acuminata: a randomized, double-blind, placebo-controlled study of intralesional therapy

21 January 2018

1 reference

Systemic α-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: Double-blind, placebo-controlled trial

21 January 2018

1 reference

Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

21 January 2018

1 reference

Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

21 January 2018

1 reference

The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication

21 January 2018

1 reference

Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1

21 January 2018

1 reference

Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1.

21 January 2018

1 reference

Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up

21 January 2018

1 reference

Antiviral drug discovery and development: where chemistry meets with biomedicine

21 January 2018

1 reference

Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.

21 January 2018

1 reference

Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity

21 January 2018

1 reference

Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity

21 January 2018

1 reference

Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease

21 January 2018

1 reference

Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.

21 January 2018

1 reference

Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis

21 January 2018

1 reference

Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.

21 January 2018

1 reference

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection

21 January 2018

1 reference

Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia

21 January 2018

1 reference

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

21 January 2018

1 reference

E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells

21 January 2018

1 reference

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

21 January 2018

1 reference

RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.

21 January 2018

1 reference

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy

21 January 2018

1 reference

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

Dysregulated molecular networks in head and neck carcinogenesis

21 January 2018

1 reference

Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas

21 January 2018

1 reference

Nuclear translocation of β-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumour progression?

21 January 2018

1 reference

How an inhibitor of the HIV-I protease modulates proteasome activity

21 January 2018

1 reference

Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins

21 January 2018

1 reference

Cell-permeable artificial zinc-finger proteins as potent antiviral drugs for human papillomaviruses

21 January 2018

1 reference

HPV16 tumor associated macrophages suppress antitumor T cell responses.

21 January 2018

1 reference

Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells

21 January 2018

1 reference

More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia

21 January 2018

1 reference

Alpha interferon augments cidofovir's antiviral and antiproliferative activities

21 January 2018

1 reference

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis

21 January 2018

1 reference

Role of human papillomavirus in the development of head and neck squamous cell carcinomas

21 January 2018

1 reference

The regulation of cell proliferation by the papillomavirus early proteins

21 January 2018

1 reference

A new type of human papillomavirus associated with oral focal epithelial hyperplasia

21 January 2018

1 reference

Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma.

21 January 2018

1 reference

HPV infections in benign and malignant sinonasal lesions

21 January 2018

1 reference

Recurrent respiratory papillomatosis: an overview of current thinking and treatment

21 January 2018

1 reference

Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management

21 January 2018

1 reference

HPV DNA in clinically different variants of oral leukoplakia and lichen planus

21 January 2018

1 reference

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

21 January 2018

1 reference

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

21 January 2018

1 reference

Diversity of human papillomavirus types in periungual squamous cell carcinoma

21 January 2018

1 reference

Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil

21 January 2018

1 reference

Focus on head and neck cancer

21 January 2018

1 reference

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

21 January 2018

1 reference

Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia

21 January 2018

1 reference

Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx

21 January 2018

1 reference

Molecular and serological evidence of the epidemiological association of HPV 13 with focal epithelial hyperplasia: A case-control study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.714

1 reference

25 August 2017

1 reference